Cost-effectiveness of newer treatment strategies for influenza

This publication has 15 references indexed in Scilit:

• Influenza virus neuraminidase inhibitors
  The Lancet, 2000
• Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza
  JAMA, 2000
• Toward Consistency in Cost-Utility Analyses
  Medical Care, 1998
• Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus Infections
  New England Journal of Medicine, 1997
• Cost - Effectiveness Analysis, Extended Dominance, and Ethics
  Medical Decision Making, 1994
• Clinical Economics
  JAMA, 1989
• Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78.
  American Journal of Public Health, 1986
• A Controlled Trial of Amantadine and Rimantadine in the Prophylaxis of Influenza a Infection
  New England Journal of Medicine, 1982
• Evaluation of Amantadine in the Prophylaxis of Influenza A (H1N1) Virus Infection: A Controlled Field Trial among Young Adults and High-Risk Patients
  The Journal of Infectious Diseases, 1980
• The utility of different health states as perceived by the general public
  Journal of Chronic Diseases, 1978